Cybin Future Growth
Future criteria checks 0/6
Cybin is forecast to grow earnings and revenue by 62.2% and 68.7% per annum respectively. EPS is expected to grow by 57% per annum. Return on equity is forecast to be -29.5% in 3 years.
Key information
62.2%
Earnings growth rate
57.0%
EPS growth rate
Pharmaceuticals earnings growth | 56.7% |
Revenue growth rate | 68.7% |
Future return on equity | -29.5% |
Analyst coverage | Low |
Last updated | 13 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 117 | 5 | 1 | -51 | 3 |
3/31/2026 | N/A | -80 | -74 | -61 | 3 |
3/31/2025 | N/A | -66 | -57 | -50 | 3 |
3/31/2024 | N/A | -74 | -61 | -61 | 4 |
12/31/2023 | N/A | -70 | -60 | -59 | N/A |
9/30/2023 | N/A | -51 | -45 | -44 | N/A |
6/30/2023 | N/A | -49 | -50 | -47 | N/A |
3/31/2023 | N/A | -47 | -51 | -47 | N/A |
12/31/2022 | N/A | -52 | -50 | -46 | N/A |
9/30/2022 | N/A | -58 | -52 | -48 | N/A |
6/30/2022 | N/A | -66 | -48 | -47 | N/A |
3/31/2022 | N/A | -68 | -46 | -45 | N/A |
12/31/2021 | N/A | -63 | -43 | -42 | N/A |
9/30/2021 | N/A | -58 | -38 | -38 | N/A |
6/30/2021 | N/A | -43 | -27 | -26 | N/A |
3/31/2021 | 1 | -32 | -19 | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CYBN is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CYBN is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CYBN is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CYBN is forecast to have no revenue next year.
High Growth Revenue: CYBN is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CYBN is forecast to be unprofitable in 3 years.